Alvaro Monteiro - Publications

Affiliations: 
Biology (Cell Biology, Microbiology, Molecular Biology) University of South Florida, Tampa, FL, United States 
Area:
Molecular Biology

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Monteiro AN, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839  0.32
2015 Baskin R, Woods NT, Mendoza-Fandiño G, Forsyth P, Egan KM, Monteiro AN. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. Scientific Reports. 5: 17367. PMID 26610392 DOI: 10.1038/Srep17367  1
2015 Zhang C, Doherty JA, Burgess S, Hung RJ, Lindström S, Kraft P, Gong J, Amos C, Sellers TA, Monteiro AN, Chenevix-Trench G, Bickeböller H, Risch A, Brennan P, McKay J, et al. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Human Molecular Genetics. PMID 26138067 DOI: 10.1093/Hmg/Ddv252  1
2015 Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Couch FJ, Offit K, Chenevix-Trench G, ... Monteiro AN, et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24: 3595-607. PMID 25804953 DOI: 10.1093/Hmg/Ddv101  1
2015 Jhuraney A, Velkova A, Johnson RC, Kessing B, Carvalho RS, Whiley P, Spurdle AB, Vreeswijk MP, Caputo SM, Millot GA, Vega A, Coquelle N, Galli A, Eccles D, Blok MJ, ... ... Monteiro AN, et al. BRCA1 Circos: a visualisation resource for functional analysis of missense variants. Journal of Medical Genetics. 52: 224-30. PMID 25643705 DOI: 10.1136/Jmedgenet-2014-102766  1
2015 Egan KM, Baskin R, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Monteiro AN. Brain tumor risk according to germ-line variation in the MLLT10 locus. European Journal of Human Genetics : Ejhg. 23: 132-4. PMID 24755950 DOI: 10.1038/ejhg.2014.70  1
2015 Eccles EB, Mitchell G, Monteiro ANA, Schmutzler R, Couch FJ, Spurdle AB, Gómez-García EB, Driessen R, Lindor NM, Blok MJ, Moller P, de la Hoya M, Pal T, Domchek S, Nathanson K, et al. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance Annals of Oncology. 26: 2057-2065. DOI: 10.1093/annonc/mdv278  1
2014 Iversen ES, Lipton G, Clyde MA, Monteiro AN. Functional annotation signatures of disease susceptibility loci improve SNP association analysis. Bmc Genomics. 15: 398. PMID 24886216 DOI: 10.1186/1471-2164-15-398  1
2014 Carvalho RS, Abreu RBV, Velkova A, Marsillac S, Rodarte RS, Suarez-Kurtz G, Iversen ES, Monteiro ANA, Carvalho MA. Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1 Plos One. 9. PMID 24845084 DOI: 10.1371/Journal.Pone.0097766  1
2014 Guidugli L, Carreira A, Caputo SM, Ehlen A, Galli A, Monteiro AN, Neuhausen SL, Hansen TV, Couch FJ, Vreeswijk MP. Functional assays for analysis of variants of uncertain significance in BRCA2. Human Mutation. 35: 151-64. PMID 24323938 DOI: 10.1002/humu.22478  1
2014 Madden MH, Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, Monteiro AN, Egan KM. Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes & Control : Ccc. 25: 25-32. PMID 24135790 DOI: 10.1007/S10552-013-0305-Y  1
2013 Tulchin N, Ornstein L, Dikman S, Strauchen J, Jaffer S, Nagi C, Bleiweiss I, Kornreich R, Edelmann L, Brown K, Bodian C, Nair VD, Chambon M, Woods NT, Monteiro AN. Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Cancer Cell International. 13: 70. PMID 23855721 DOI: 10.1186/1475-2867-13-70  1
2013 Quiles F, Fernández-Rodríguez J, Mosca R, Feliubadaló L, Tornero E, Brunet J, Blanco I, Capellá G, Pujana MÀ, Aloy P, Monteiro A, Lázaro C. Functional and structural analysis of C-terminal BRCA1 missense variants. Plos One. 8: e61302. PMID 23613828 DOI: 10.1371/Journal.Pone.0061302  1
2013 Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Monteiro AN, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629  1
2013 Pal T, Bonner D, Kim J, Monteiro AN, Kessler L, Royer R, Narod SA, Vadaparampil ST. Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics. The Breast Journal. 19: 189-92. PMID 23320992 DOI: 10.1111/Tbj.12083  1
2013 Domchek SM, Tang J, Stopfer J, Lilli DR, Hamel N, Tischkowitz M, Monteiro AN, Messick TE, Powers J, Yonker A, Couch FJ, Goldgar DE, Davidson HR, Nathanson KL, Foulkes WD, et al. Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer. Cancer Discovery. 3: 399-405. PMID 23269703 DOI: 10.1158/2159-8290.Cd-12-0421  1
2012 Woods NT, Mesquita RD, Sweet M, Carvalho MA, Li X, Liu Y, Nguyen H, Thomas CE, Iversen ES, Marsillac S, Karchin R, Koomen J, Monteiro AN. Charting the landscape of tandem BRCT domain-mediated protein interactions. Science Signaling. 5: rs6. PMID 22990118 DOI: 10.1126/Scisignal.2002255  1
2012 Millot GA, Carvalho MA, Caputo SM, Vreeswijk MP, Brown MA, Webb M, Rouleau E, Neuhausen SL, Hansen Tv, Galli A, Brandão RD, Blok MJ, Velkova A, Couch FJ, Monteiro AN, et al. A guide for functional analysis of BRCA1 variants of uncertain significance. Human Mutation. 33: 1526-37. PMID 22753008 DOI: 10.1002/Humu.22150  1
2012 Egan KM, Nabors LB, Olson JJ, Monteiro AN, Browning JE, Madden MH, Thompson RC. Rare TP53 genetic variant associated with glioma risk and outcome. Journal of Medical Genetics. 49: 420-1. PMID 22706378 DOI: 10.1136/jmedgenet-2012-100941  1
2012 Gerloff DL, Woods NT, Farago AA, Monteiro AN. BRCT domains: A little more than kin, and less than kind. Febs Letters. 586: 2711-6. PMID 22584059 DOI: 10.1016/J.Febslet.2012.05.005  1
2012 Velkova A, Monteiro AN. CHEKing out of mitosis. Cell Cycle (Georgetown, Tex.). 11: 1756. PMID 22510558 DOI: 10.4161/Cc.20315  1
2011 Velkova A, Monteiro AN. Epigenetic tumor suppression by BRCA1. Nature Medicine. 17: 1183-5. PMID 21988990 DOI: 10.1038/Nm.2493  1
2011 Liu Y, Woods NT, Kim D, Sweet M, Monteiro AN, Karchin R. Yeast two-hybrid junk sequences contain selected linear motifs. Nucleic Acids Research. 39: e128. PMID 21785140 DOI: 10.1093/Nar/Gkr600  1
2011 Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nature Genetics. 43: 513-8. PMID 21614091 DOI: 10.1038/Ng.840  1
2011 Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Bloom G, Chanock SJ, Chen Z, Cramer DW, Cunningham JM, Dagne G, Ebbert-Syfrett J, Fenstermacher D, ... ... Monteiro AN, et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Research. 71: 3896-903. PMID 21482675 DOI: 10.1158/0008-5472.Can-10-4167  1
2011 Iversen ES, Couch FJ, Goldgar DE, Tavtigian SV, Monteiro AN. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1078-88. PMID 21447777 DOI: 10.1158/1055-9965.Epi-10-1214  1
2011 Woods NT, Nguyen H, Carvalho M, Li X, Dapic V, Monteiro A. Abstract 3892: Discovery and analysis of COMMD1 in the DNA damage response network Cancer Research. 71: 3892-3892. DOI: 10.1158/1538-7445.Am2011-3892  0.6
2010 Freeman AK, Monteiro AN. Phosphatases in the cellular response to DNA damage. Cell Communication and Signaling : Ccs. 8: 27. PMID 20860841 DOI: 10.1186/1478-811X-8-27  1
2010 Lee MS, Green R, Marsillac SM, Coquelle N, Williams RS, Yeung T, Foo D, Hau DD, Hui B, Monteiro AN, Glover JN. Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Research. 70: 4880-90. PMID 20516115 DOI: 10.1158/0008-5472.Can-09-4563  1
2010 Velkova A, Carvalho MA, Johnson JO, Tavtigian SV, Monteiro AN. Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair. Cell Cycle (Georgetown, Tex.). 9: 1421-33. PMID 20305393 DOI: 10.4161/Cc.9.7.11256  1
2010 Freeman AK, Dapic V, Monteiro AN. Negative regulation of CHK2 activity by protein phosphatase 2A is modulated by DNA damage. Cell Cycle (Georgetown, Tex.). 9: 736-47. PMID 20160490 DOI: 10.4161/Cc.9.4.10613  1
2009 De Ligio JT, Velkova A, Zorio DA, Monteiro AN. Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy? Anti-Cancer Agents in Medicinal Chemistry. 9: 543-9. PMID 19519295 DOI: 10.2174/187152009788451798  1
2009 Rios-Doria J, Velkova A, Dapic V, Galán-Caridad JM, Dapic V, Carvalho MA, Melendez J, Monteiro AN. Ectopic expression of histone H2AX mutants reveals a role for its post-translational modifications. Cancer Biology & Therapy. 8: 422-34. PMID 19305155 DOI: 10.4161/Cbt.8.5.7592  1
2009 Carvalho M, Pino MA, Karchin R, Beddor J, Godinho-Netto M, Mesquita RD, Rodarte RS, Vaz DC, Monteiro VA, Manoukian S, Colombo M, Ripamonti CB, Rosenquist R, Suthers G, Borg A, ... ... Monteiro AN, et al. Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1. Mutation Research. 660: 1-11. PMID 18992264 DOI: 10.1016/J.Mrfmmm.2008.09.017  1
2008 Couch FJ, Rasmussen LJ, Hofstra R, Monteiro AN, Greenblatt MS, de Wind N. Assessment of functional effects of unclassified genetic variants. Human Mutation. 29: 1314-26. PMID 18951449 DOI: 10.1002/humu.20899  1
2007 Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. American Journal of Human Genetics. 81: 873-83. PMID 17924331 DOI: 10.1086/521032  1
2007 Carvalho MA, Marsillac SM, Karchin R, Manoukian S, Grist S, Swaby RF, Urmenyi TP, Rondinelli E, Silva R, Gayol L, Baumbach L, Sutphen R, Pickard-Brzosowicz JL, Nathanson KL, Sali A, ... ... Monteiro AN, et al. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Research. 67: 1494-501. PMID 17308087 DOI: 10.1158/0008-5472.Can-06-3297  1
2007 Karchin R, Monteiro AN, Tavtigian SV, Carvalho MA, Sali A. Functional impact of missense variants in BRCA1 predicted by supervised learning. Plos Computational Biology. 3: e26. PMID 17305420 DOI: 10.1371/Journal.Pcbi.0030026  1
2006 Dapić V, Monteiro AN. Functional implications of BRCA1 for early detection, prevention, and treatment of breast cancer. Critical Reviews in Eukaryotic Gene Expression. 16: 233-52. PMID 17073553  1
2006 Chiarini LB, Takiya CM, Borojevic R, Monteiro AN. Long-term culture of cholangiocytes from liver fibro-granulomatous lesions. Bmc Gastroenterology. 6: 13. PMID 16584555 DOI: 10.1186/1471-230X-6-13  1
2006 Rios-Doria J, Fay A, Velkova A, Monteiro AN. DNA damage response: determining the fate of phosphorylated histone H2AX. Cancer Biology & Therapy. 5: 142-4. PMID 16552174 DOI: 10.4161/Cbt.5.2.2530  1
2006 Monteiro ANA. Involvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases Biochimie. 88: 905-911. PMID 16546311 DOI: 10.1016/j.biochi.2006.01.013  1
2005 Dapic V, Carvalho MA, Monteiro AN. Breast cancer susceptibility and the DNA damage response. Cancer Control : Journal of the Moffitt Cancer Center. 12: 127-36. PMID 15855896  1
2004 Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. American Journal of Human Genetics. 75: 535-44. PMID 15290653 DOI: 10.1086/424388  1
2003 Monteiro AN. BRCA1: the enigma of tissue-specific tumor development. Trends in Genetics : Tig. 19: 312-5. PMID 12801723 DOI: 10.1016/S0168-9525(03)00110-0  1
2003 Summy JM, Sudol M, Eck MJ, Monteiro AN, Gatesman A, Flynn DC. Specificity in signaling by c-Yes. Frontiers in Bioscience : a Journal and Virtual Library. 8: s185-205. PMID 12456296 DOI: 10.2741/1011  1
2002 Monteiro ANA. Participation of BRCA1 in the DNA repair response...via transcription Cancer Biology and Therapy. 1: 187-188.  1
2000 Monteiro ANA. BRCA1: Exploring the links to transcription Trends in Biochemical Sciences. 25: 469-474. PMID 11050427 DOI: 10.1016/S0968-0004(00)01632-7  1
Show low-probability matches.